# Hub Group, Inc.: financial statements, quarterly

HUBG · Nasdaq · CIK 940942 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hubg.md) · [Financials](/companies/hubg/financials.md) · [Filings](/companies/hubg/filings.md) · [Insiders](/companies/hubg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hubg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,286 d](/filings/0000950170-25-026866.md) | [1,152](/filings/0000950170-24-052763.md) | [1,040](/filings/0000950170-24-089971.md) | [1,025](/filings/0000950170-24-120064.md) | [985 d](/filings/0000950170-25-026866.md) | [999](/filings/0000950170-25-067857.md) | [986](/filings/0000950170-25-103905.md) | [987](/filings/0001193125-25-266623.md) | [974 d](/filings/0000950170-25-026866.md) | [915](/filings/0000950170-25-067857.md) | [906](/filings/0000950170-25-103905.md) | [934](/filings/0001193125-25-266623.md) |
| Cost of revenue | $m | [1,081 d](/filings/0000950170-23-004358.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [204 d](/filings/0000950170-23-004358.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [104 d](/filings/0000950170-25-026866.md) | [78.2](/filings/0000950170-24-052763.md) | [62.1](/filings/0000950170-24-089971.md) | [42.6](/filings/0000950170-24-120064.md) | [29.4 d](/filings/0000950170-25-026866.md) | [37.1](/filings/0000950170-25-067857.md) | [39.5](/filings/0000950170-25-103905.md) | [32.1](/filings/0001193125-25-266623.md) | [31.5 d](/filings/0000950170-25-026866.md) | [37.3](/filings/0000950170-25-067857.md) | [34.3](/filings/0000950170-25-103905.md) | [39.4](/filings/0001193125-25-266623.md) |
| Interest expense | $m | [2.2 d](/filings/0000950170-24-021432.md) | [3.0](/filings/0000950170-24-052763.md) | [3.1](/filings/0000950170-24-089971.md) | [3.5](/filings/0000950170-23-058706.md) | [3.8 d](/filings/0000950170-24-021432.md) | [3.9](/filings/0000950170-24-052763.md) | [3.7](/filings/0000950170-24-089971.md) | [3.6](/filings/0001193125-25-266623.md) | [3.3 d](/filings/0000950170-25-026866.md) | [3.2](/filings/0000950170-25-067857.md) | [3.1](/filings/0000950170-25-103905.md) | [3.0](/filings/0001193125-25-266623.md) |
| Income tax | $m | [23.9 d](/filings/0000950170-25-026866.md) | [14.9](/filings/0000950170-24-052763.md) | [14.6](/filings/0000950170-24-089971.md) | [11.2](/filings/0000950170-24-120064.md) | [1.0 d](/filings/0000950170-25-026866.md) | [7.4](/filings/0000950170-25-067857.md) | [8.6](/filings/0000950170-25-103905.md) | [7.1](/filings/0001193125-25-266623.md) | [5.4 d](/filings/0000950170-25-026866.md) | [8.4](/filings/0000950170-25-067857.md) | [7.9](/filings/0000950170-25-103905.md) | [9.6](/filings/0001193125-25-266623.md) |
| Net income | $m | [79.3 d](/filings/0000950170-25-026866.md) | [61.8](/filings/0000950170-24-052763.md) | [46.5](/filings/0000950170-24-089971.md) | [30.5](/filings/0000950170-24-120064.md) | [28.8 d](/filings/0000950170-25-026866.md) | [27.1](/filings/0000950170-25-067857.md) | [29.0](/filings/0000950170-25-103905.md) | [23.6](/filings/0001193125-25-266623.md) | [24.3 d](/filings/0000950170-25-026866.md) | [26.8](/filings/0000950170-25-067857.md) | [25.2](/filings/0000950170-25-103905.md) | [28.6](/filings/0001193125-25-266623.md) |
| Diluted EPS | $ per share | not reported | [0.94](/filings/0000950170-24-052763.md) | [0.72](/filings/0000950170-24-089971.md) | [0.48](/filings/0000950170-24-120064.md) | not reported | [0.44](/filings/0000950170-25-067857.md) | [0.47](/filings/0000950170-25-103905.md) | [0.39](/filings/0001193125-25-266623.md) | not reported | [0.44](/filings/0000950170-25-067857.md) | [0.42](/filings/0000950170-25-103905.md) | [0.47](/filings/0001193125-25-266623.md) |
| Basic EPS | $ per share | not reported | [0.95](/filings/0000950170-24-052763.md) | [0.73](/filings/0000950170-24-089971.md) | [0.49](/filings/0000950170-24-120064.md) | not reported | [0.44](/filings/0000950170-25-067857.md) | [0.48](/filings/0000950170-25-103905.md) | [0.39](/filings/0001193125-25-266623.md) | not reported | [0.45](/filings/0000950170-25-067857.md) | [0.42](/filings/0000950170-25-103905.md) | [0.48](/filings/0001193125-25-266623.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [287](/filings/0000950170-24-021432.md) | [343](/filings/0000950170-23-018273.md) | [342](/filings/0000950170-23-038573.md) | [401](/filings/0000950170-23-058706.md) | [187](/filings/0000950170-25-026866.md) | [195](/filings/0000950170-24-052763.md) | [220](/filings/0000950170-24-089971.md) | [186](/filings/0000950170-24-120064.md) | [98.2](/filings/0001193125-25-266623.md) | [113](/filings/0000950170-25-067857.md) | [137](/filings/0000950170-25-103905.md) | [120](/filings/0001193125-25-266623.md) |
| Current assets | $m | [1,057](/filings/0000950170-24-021432.md) | [1,072](/filings/0000950170-23-018273.md) | [990](/filings/0000950170-23-038573.md) | [1,083](/filings/0000950170-23-058706.md) | [849](/filings/0000950170-25-026866.md) | [828](/filings/0000950170-24-052763.md) | [837](/filings/0000950170-24-089971.md) | [805](/filings/0000950170-24-120064.md) | [768](/filings/0001193125-25-266623.md) | [753](/filings/0000950170-25-067857.md) | [745](/filings/0000950170-25-103905.md) | [788](/filings/0001193125-25-266623.md) |
| Total assets | $m | [2,810](/filings/0000950170-24-021432.md) | [2,888](/filings/0000950170-23-018273.md) | [2,800](/filings/0000950170-23-038573.md) | [2,918](/filings/0000950170-23-058706.md) | [2,936](/filings/0000950170-25-026866.md) | [2,891](/filings/0000950170-24-052763.md) | [2,859](/filings/0000950170-24-089971.md) | [2,833](/filings/0000950170-24-120064.md) | [2,868](/filings/0001193125-25-266623.md) | [2,822](/filings/0000950170-25-067857.md) | [2,800](/filings/0000950170-25-103905.md) | [2,901](/filings/0001193125-25-266623.md) |
| Current liabilities | $m | [692](/filings/0000950170-24-021432.md) | [638](/filings/0000950170-23-018273.md) | [594](/filings/0000950170-23-038573.md) | [656](/filings/0000950170-23-058706.md) | [658](/filings/0000950170-25-026866.md) | [649](/filings/0000950170-24-052763.md) | [635](/filings/0000950170-24-089971.md) | [618](/filings/0000950170-24-120064.md) | [579](/filings/0001193125-25-266623.md) | [555](/filings/0000950170-25-067857.md) | [526](/filings/0000950170-25-103905.md) | [535](/filings/0001193125-25-266623.md) |
| Long-term debt | $m | [241](/filings/0000950170-24-021432.md) | [236](/filings/0000950170-23-018273.md) | [238](/filings/0000950170-23-038573.md) | [244](/filings/0000950170-23-058706.md) | [246](/filings/0000950170-25-026866.md) | [231](/filings/0000950170-24-052763.md) | [210](/filings/0000950170-24-089971.md) | [187](/filings/0000950170-24-120064.md) | [164](/filings/0001193125-25-266623.md) | [153](/filings/0000950170-25-067857.md) | [134](/filings/0000950170-25-103905.md) | [160](/filings/0001193125-25-266623.md) |
| Current portion of debt | $m | [102](/filings/0000950170-24-021432.md) | [97.9](/filings/0000950170-23-018273.md) | [98.4](/filings/0000950170-23-038573.md) | [103](/filings/0000950170-23-058706.md) | [105](/filings/0000950170-25-026866.md) | [104](/filings/0000950170-24-052763.md) | [103](/filings/0000950170-24-089971.md) | [99.9](/filings/0000950170-24-120064.md) | [100](/filings/0001193125-25-266623.md) | [99.6](/filings/0000950170-25-067857.md) | [97.6](/filings/0000950170-25-103905.md) | [94.5](/filings/0001193125-25-266623.md) |
| Shareholders' equity | $m | [1,600](/filings/0000950170-24-120064.md) | [1,659](/filings/0000950170-24-089971.md) | [1,611](/filings/0000950170-24-120064.md) | [1,629](/filings/0000950170-24-120064.md) | [1,635](/filings/0000950170-25-026866.md) | [1,622](/filings/0000950170-24-089971.md) | [1,641](/filings/0000950170-24-120064.md) | [1,626](/filings/0000950170-24-120064.md) | [1,645](/filings/0001193125-25-266623.md) | [1,649](/filings/0000950170-25-067857.md) | [1,675](/filings/0000950170-25-103905.md) | [1,702](/filings/0001193125-25-266623.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [108 d](/filings/0000950170-25-026866.md) | [89.4](/filings/0000950170-24-052763.md) | [132 d](/filings/0000950170-24-089971.md) | [101 d](/filings/0000950170-24-120064.md) | [99.5 d](/filings/0000950170-25-026866.md) | [80.5](/filings/0000950170-25-067857.md) | [69.9 d](/filings/0000950170-25-103905.md) | [43.4 d](/filings/0001193125-25-266623.md) | [0.6 d](/filings/0000950170-25-026866.md) | [70.0](/filings/0000950170-25-067857.md) | [61.5 d](/filings/0000950170-25-103905.md) | [28.1 d](/filings/0001193125-25-266623.md) |
| Capital expenditure | $m | [61.5 d](/filings/0000950170-25-026866.md) | [26.8](/filings/0000950170-24-052763.md) | [38.8 d](/filings/0000950170-24-089971.md) | [40.0 d](/filings/0000950170-24-120064.md) | [34.4 d](/filings/0000950170-25-026866.md) | [17.5](/filings/0000950170-25-067857.md) | [13.7 d](/filings/0000950170-25-103905.md) | [12.0 d](/filings/0001193125-25-266623.md) | [7.6 d](/filings/0000950170-25-026866.md) | [19.2](/filings/0000950170-25-067857.md) | [11.3 d](/filings/0000950170-25-103905.md) | [8.7 d](/filings/0001193125-25-266623.md) |
| Dividends paid | $m | not reported | [0.0](/filings/0000950170-24-052763.md) | [0.0 d](/filings/0000950170-24-089971.md) | [0.0 d](/filings/0000950170-24-120064.md) | [0.0 d](/filings/0000950170-25-026866.md) | [7.6](/filings/0000950170-25-067857.md) | [7.6 d](/filings/0000950170-25-103905.md) | [7.5 d](/filings/0001193125-25-266623.md) | [7.5 d](/filings/0000950170-25-026866.md) | [7.5](/filings/0000950170-25-067857.md) | [7.5 d](/filings/0000950170-25-103905.md) | [7.5 d](/filings/0001193125-25-266623.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-25-026866.md) | [0.0](/filings/0000950170-24-052763.md) | [100 d](/filings/0000950170-24-089971.md) | [17.3 d](/filings/0000950170-24-120064.md) | [26.4 d](/filings/0000950170-25-026866.md) | [25.8](/filings/0000950170-25-067857.md) | [7.2 d](/filings/0000950170-25-103905.md) | [35.3 d](/filings/0001193125-25-266623.md) | [0.0 d](/filings/0000950170-25-026866.md) | [13.8](/filings/0000950170-25-067857.md) | [0.0 d](/filings/0000950170-25-103905.md) | [0.0 d](/filings/0001193125-25-266623.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [34.0](/filings/0000950170-23-018273.md) | [33.9](/filings/0000950170-23-038573.md) | [33.5](/filings/0000950170-23-058706.md) | [65.7](/filings/0000950170-24-052763.md) | [64.6](/filings/0000950170-24-089971.md) | [63.0](/filings/0000950170-24-120064.md) | [61.7](/filings/0000950170-25-067857.md) | [61.1](/filings/0000950170-25-103905.md) | [60.9](/filings/0001193125-25-266623.md) | [60.4](/filings/0000950170-25-067857.md) | [60.2](/filings/0000950170-25-103905.md) | [60.3](/filings/0001193125-25-266623.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 37,315,154 at 2010-10-21, from the cover of the [10-Q filed 2010-10-25](/filings/0000940942-10-000029.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.